Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Patent
1999-04-13
1999-12-07
Stockton, Laura L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
530300, 530331, 560158, A61K 3127, C07D27500, C07D27120
Patent
active
059984708
ABSTRACT:
Disclosed herein is a compound of the formula ##STR1## known as 2-[N-(N-benzyloxycarbonyl-L-leucinyl)]-2'-[N'-[4-(N,N-dimethylaminomethyl) benzyloxy]carbonyl-L-leucinyl]carbohydrazide; and pharmaceutically acceptable salts, hydrates and solvates thereof.
REFERENCES:
patent: 4038247 (1977-07-01), Muller et al.
patent: 4447419 (1984-05-01), Quadro
patent: 4518528 (1985-05-01), Rasnick
patent: 4638010 (1987-01-01), Weller, III et al.
patent: 4749792 (1988-06-01), Natarajan et al.
patent: 4994471 (1991-02-01), Lalinde et al.
patent: 5057525 (1991-10-01), Van Daele
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5206251 (1993-04-01), Khanna et al.
patent: 5216168 (1993-06-01), Khanna et al.
patent: 5374637 (1994-12-01), Van Daele
patent: 5395824 (1995-03-01), Higuchi et al.
patent: 5422359 (1995-06-01), Ando et al.
patent: 5424325 (1995-06-01), Ando et al.
patent: 5501969 (1996-03-01), Hastings et al.
patent: 5523313 (1996-06-01), Nunami et al.
patent: 5585387 (1996-12-01), Lu et al.
patent: 5668128 (1997-09-01), Tsubotani et al.
patent: 5830850 (1998-11-01), Gelb et al.
patent: 5861298 (1999-01-01), Adams et al.
Bossard, et al., (1996), J. of Bio. Chem;, vol. 271, No. 21, pp. 12517-12524.
Bromme, et al., (1996), Biochemical Journal, vol. 315, pp. 85-89, especially abstract, Fig. 1.
Velasco, et al., (1994), J. of Bio. Chem; vol. 269, No. 43 pp. 27136-27142 especially the abstract.
Magrath, et al, (1992), J. of Med. Chem; vol. 35, No. 23 pp. 4279-4283, especially page 4281, col. 1, structures 1-4 and 7.
Graybill, et al., (1992), Bioorganic & Medicinal Chemistry Letters; vol. 2, No. 11, pp. 1375-1380, especially page 1377, Scheme I.
Palmer, et al., (1995), J. of Med. Chem; vol. 38. No. 17, pp. 3193-3196.
Danheiser, (1995), Genetic Engineering News; vol. 15, No. 17, pp. 1-1 and 35-36.
Rasnick, (1996), Perspectives in Drug Discovery & Design; vol. 6, pp. 48-63.
Potempa, et al., "Host and Porphyromonas gingivalis proteinases in periodontitis: A biochemical model of infection and tissue destruction", (1994), Perspectives in Drug Discovery and Design, vol. 2, pp. 445-458.
Drake, et al., "Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts", (1996), J. of Biological Chemistry, 271(21), pp. 12511-12516.
Bromme, et al., "Human Cathespin 02, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts", (1996), J. of Biological Chemistry, 271(4), pp. 2126-2132.
Delaisse, et al., "In Vivo and In Vitro Evidence for the Involvement of Cysteine Proteinases in Bone Resorption", (1994), Biochemical and Biophysical Research Communications, 125(2), pp. 441-447.
Delaisse, et al., "Inhibition of bone resorption in culture by inhibitors of thiol proteinases", (1980), Biochem. J., 192, pp. 365-368.
Lerner, et al., "Human Cystatin C, a Cysteine Proteinase Inhibitor, Inhibits Bone Resporption In Vitro Stimulated by Parathroid Hormone and Parathyroid Hormone-Related Peptide of Malignancy", (1992), J. of Bone and Mineral Research, 7(4), pp. 433-439.
Hill, et al., "Inhibition of Bone Resorption by Selective Inactivators of Cysteine Proteinases", (1994), J. of Cellular Biochemistry, 56, pp. 118-130.
Delaise, et al., "The Effects of Inhibitors of Cysteine-Proteinases and Collagenase on the Resorptive Activity of Isolated Osteoclasts", Bone, 8, pp. 305-313, 1987.
Borg, et al., "Total Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomietics", J. Org. Chem., 60, pp. 3112-3120, 1995.
Boden, et al., "Total Synthesis of Lissoclinamide 5, a Cytotoxic Cyclic Peptide frm the Tunicate Lissoclinum patella ", (1994), Tetrahedron. Ltrs., 35(44), pp. 8271-8274.
Everts, et al., "Degradation of Collagen in the Bone-Resorbing Compartment Underlying the Osteoclast Involves Both Cysteine-Proteinases and Matrix Metalloproteinases", (1992), Journal of Cellular Physiology, 150, pp. 221-231.
Shi, et al., "Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2", (1995), FEBS Ltrs., 357, pp. 129-134.
Inaoka, et al., "Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in Bone", (1995), Biochemical and Biophysical Research Communications, 206(1), pp. 89-96.
Elmore, et al., "A New Method for Determining the Absolute Molarity of Solutions of Trypsin and Chymotrypsin. . . ", (1968), Biochem J., 107, pp. 103-107.
Barker, et al., "The Reaction of an .alpha.-Aza-Amino Acid Derivative with Chymotrypsin and Its Use as a Ligand. . . ", (1974), Biochem J., 139, 555-563.
Gray, et al., "N.sup..alpha. -Ethyloxcarbonyl-.alpha.-Azaornithine Phen. . .", (1977), Tetrahedron, 33, pp. 837-840.
Tezuka, et al., "Molecular Cloning of a Possible Cysteine Proteinase Predominantly Expressed in Osteoclasts", (1994), J. Biolog. Chem., 269(2), pp. 1106-1109.
Gupton, et al., "Reaction of Azapeptides with Chymotrypsin-like Enzymes", (1984), J. Biol. Chem., 259:7, pp. 4279-4287.
Powers, et al., "Reaction of Azapeptides with Human Leukocyte Elastase and Pricine Pancreatic Elastase", (1984), J. Bioi. Chem., 259:7, pp. 4288-4294.
McConnell, et al., "New Leupeptin Analogues: Synthesis and Inhibition Data", J. Med. Chem, 33, pp. 86-93, 1990.
Umezawa, "Structures and Activities of Protease Inhibitors of Microbial Origin", Meth. Enzymol., pp. 678-695, 1976.
Barrett, et al., "L-trans-Epoxysuccinyl-leucylamido(4-guandino)butane9E-64) and its analogues. . .", (1982), Biochem. J., 210, pp. 189-198.
Han et al., Azatides: "Solution and Liquid Phase Syntheses of a New Peptidomimetic", (1996), J. Amer. Chem. Soc., 118:11, pp. 2539-2544.
Grinde, "Selective Inhibition of Lysomal Protein Degradation By the Thiol Proteinase. . ."(1982), Biochem. J. Biophys. Acta., 701, pp. 328-333.
Baggio, et al., "From Poor Substrates to Good Inhibitors: Design of Inhibitors for Serive and Thiol Proteases", (1996), Biochem., 35:11, pp. 3351-3353.
Calabretta, et al., "Peptidyl and azapeptidyl methylketones as substrate analog inhibitors of papain and cathepsin B", (1995), Eur. J. Med. Chem., 30, pp. 931-941.
McConnell, et al., "Inhibition Studies of Some Serine and Thiol Proteinases by New Leupeptin Analogues", (1993), J. Med. Chem, 36, pp. 1084-1089.
Afridi, et al., "Heterocyclic Rearrangements. Part XIV. Attempts to Activate Ring-opening-Ring-closure Rearrangements with Carbon as the Central Atom", (1976), J.C.S. Perkin Trans I, vol. 3, pp. 315-320.
Kosary, et al., "Synthesis of pyridylthiazoles as antisecretory agents", (1989), Pharmazie, 44:3, pp. 191-193.
Sridevi, et al., "Some reactions and rearrangements of isoxazol-3-carbonyl azides and hydrazides", (1990), Indian J. of Chem., 29B:2, pp. 182-183.
Greenlee, et al., "Azapeptides: A New Class of Angiotensin-Converting Enzyme Inhibitors", (1984), Biochem. & Biophys. Research Communications, 122:2, pp. 791-797.
Auger, et al., "Solid-State 13C NMR Study of a Transglutaminase-Inhibitor Adduct", (1993), Biochemistry, vol. 32, No. 15, pp. 3930-3934.
Castlehano, et al., "Synthesis, Chemistry and Absolute Configuration of Novel Transglutaminase Inhibitors Containing a 3-Halo-4,5-dihydroisoxazole", (1988), Bioorg. Chem., vol. 16, No. 3, pp. 335-340.
Kawada, et al., "Polymer Compositions", (1971), Chemical Abstracts, vol. 83, DN 83: 180329; JP 50058142 (1975).
Thompson, et al., "Design of Potent and Selective Human Cathepsin K Inhibitors that Span the Active Site", (1997), Proc. Natl. Acad. Sci., vol. 94, pp. 14249-14254.
Halbert Stacie Marie
Thompson Scott Kevin
Veber Daniel Frank
Kinzig Charles M.
SmithKline Beecham Corporation
Stercho Yuriy P.
Stockton Laura L.
Venetianer Stephen A.
LandOfFree
Protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824529